Progress in the genetics of primary biliary cirrhosis

Seminars in Liver Disease

Volumn 31, Issue 2, 2011, Pages 147-156

  Hirschfield, Gideon M ^a   Invernizzi, Pietro ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

adaptive immunity; genome wide association study; IL12; Innate immunity; IRF5; Primary biliary cirrhosis

Indexed keywords

CASPASE 8; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P35; INTERLEUKIN 2; KERATIN; STAT4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INNATE IMMUNITY; NONHUMAN; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTIVE IMMUNITY; ANIMALS; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA ANTIGENS; HUMANS; IMMUNITY, INNATE; LIVER CIRRHOSIS, BILIARY; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 79955634917     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0031-1276644     Document Type: Article

References (66)

1. Lindor K D., Gershwin M E., Poupon R, Kaplan M, Bergasa N V., Heathcote E J., American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology 2009 50 1 291-308
2. Hirschfield G M., Heathcote E J., Gershwin M E. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 2010 139 5 1481-1496
3. Gershwin M E., Mackay I R. The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology 2008 47 2 737-745 (Pubitemid 351280742)
4. Walker J G., Bates D, Doniach D, Ball P A., Sherlock S. Chronic liver disease and mitochondrial antibodies: a family study. BMJ 1972 1 5793 146-148
5. Chohan M R. Primary biliary cirrhosis in twin sisters. Gut 1973 14 3 213-214
6. Williams M, Smith P M., Doniach D. Primary biliary cirrhosis and chronic active hepatitis in two sisters. BMJ 1976 2 6035 566
7. Gershwin M E., Selmi C, Worman H J. et al, USA PBC Epidemiology Group. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005 42 5 1194-1202 (Pubitemid 43112687)
8. Lazaridis K N., Juran B D., Boe G M. et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology 2007 46 3 785-792 (Pubitemid 47436125)
9. Jones D E., Watt F E., Metcalf J V., Bassendine M F., James O F. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999 30 3 402-407 (Pubitemid 29113227)
10. Selmi C, Mayo M J., Bach N et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004 127 2 485-492 (Pubitemid 39091897)
11. Arbour L, Rupps R, Field L et al. Characteristics of primary biliary cirrhosis in British Columbia's First Nations population. Can J Gastroenterol 2005 19 5 305-310 (Pubitemid 40812615)
12. Watt F E., James O F., Jones D E. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004 97 7 397-406 (Pubitemid 38967413)
13. Invernizzi P, Gershwin M E. The genetics of human autoimmune disease. J Autoimmun 2009 33 3-4 290-299
14. Ueno Y, Ambrosini Y M., Moritoki Y, Ridgway W M., Gershwin M E. Murine models of autoimmune cholangitis. Curr Opin Gastroenterol 2010 26 3 274-279
15. Hirschfield G M., Liu X, Xu C et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009 360 24 2544-2555
16. Karlsen T H., Franke A, Melum E et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010 138 3 1102-1111
17. Donaldson P T., Doherty D G., Hayllar K M., McFarlane I G., Johnson P J., Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991 13 4 701-706
18. Daly A K., Donaldson P T., Bhatnagar P et al, DILIGEN Study International SAE Consortium. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009 41 7 816-819
19. Donaldson P T., Baragiotta A, Heneghan M A. et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 2006 44 3 667-674 (Pubitemid 44433723)
20. Invernizzi P, Selmi C, Poli F et al. HLA DRB1 polymorphisms in 676 Italian patients with primary biliary cirrhosis and 2028 matched healthy controls. A nation-wide population based case-control study. Hepatology 2005 42 462A
21. Onishi S, Sakamaki T, Maeda T et al. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol 1994 21 6 1053-1060
22. Invernizzi P, Selmi C, Poli F et al, Italian PBC Genetic Study Group. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008 48 6 1906-1912
23. Hirschfield G M., Liu X, Han Y et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 2010 42 8 655-657
24. Nakamura M, Yasunami M, Kondo H et al, PBC Study Group in NHOSLJ. Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): The HLA-DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC. Hepatol Res 2010 40 5 494-504
25. Poupon R, Ping C, Chrtien Y et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 2008 49 6 1038-1045
26. Juran B D., Atkinson E J., Schlicht E M., Fridley B L., Lazaridis K N. Primary biliary cirrhosis is associated with a genetic variant in the 3 flanking region of the CTLA4 gene. Gastroenterology 2008 135 4 1200-1206
27. Walker E J., Hirschfield G M., Xu C et al. CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum 2009 60 4 931-937
28. Juran B D., Atkinson E J., Larson J J. et al. Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction. Hepatology 2010 52 1 223-229
29. Juran B D., Atkinson E J., Schlicht E M., Fridley B L., Petersen G M., Lazaridis K N. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology 2008 47 2 563-570 (Pubitemid 351280724)
30. Karlsen T H., Melum E, Franke A. The utility of genome-wide association studies in hepatology. Hepatology 2010 51 5 1833-1842
31. Liu X, Invernizzi P, Lu Y et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010 42 8 658-660
32. Hirschfield G M., Siminovitch K A. Toward the molecular dissection of primary biliary cirrhosis. Hepatology 2009 50 5 1347-1350
33. Invernizzi P, Miozzo M, Battezzati P M. et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004 363 9408 533-535 (Pubitemid 38229455)
34. Miozzo M, Selmi C, Gentilin B et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007 46 2 456-462 (Pubitemid 47344781)
35. Mitchell M M., Lleo A, Zammataro L et al. Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics 2011 6 1
36. Surolia I, Pirnie S P., Chellappa V et al. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature 2010 466 7303 243-247
37. Zhong B, Strnad P, Selmi C et al. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology 2009 50 2 546-554
38. Hamlyn A N., Macklon A F., James O. Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality. Gut 1983 24 10 940-945 (Pubitemid 13009581)
39. Myszor M, James O F. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease? Q J Med 1990 75 276 377-385 (Pubitemid 20160082)
40. Danielsson A, Boqvist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990 11 3 458-464 (Pubitemid 20120000)
41. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994 20 6 698-701 (Pubitemid 24216878)
42. Brind A M., Bray G P., Portmann B C., Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995 36 4 615-617
43. Floreani A, Naccarato R, Chiaramonte M. Prevalence of familial disease in primary biliary cirrhosis in Italy. J Hepatol 1997 26 3 737-738 (Pubitemid 27112743)
44. Tsuji K, Watanabe Y, Van De Water J et al. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun 1999 13 1 171-178 (Pubitemid 29367022)
45. Bittencourt P L., Farias A Q., Abrantes-Lemos C P. et al. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2004 19 8 873-878 (Pubitemid 39093203)
46. Olafsson S, Gudjonsson H, Selmi C et al. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol 2004 99 11 2143-2146 (Pubitemid 39524704)
47. Hayase Y, Iwasaki S, Akisawa N et al. Similar anti-mitochondrial antibody reactivity profiles in familial primary biliary cirrhosis. Hepatol Res 2005 33 1 33-38 (Pubitemid 41447881)
48. Yanagisawa M, Takagi H, Takahashi H et al. Familial clustering and genetic background of primary biliary cirrhosis in Japan. Dig Dis Sci 2010 55 9 2651-2658
49. Invernizzi P, Battezzati P M., Crosignani A et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 2003 38 4 401-406 (Pubitemid 36399240)
50. Zappala F, Grove J, Watt F E. et al. No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. J Hepatol 1998 28 5 820-823 (Pubitemid 28223486)
51. Matsushita M, Tanaka A, Kikuchi K et al. Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients. Autoimmunity 2002 35 8 531-536 (Pubitemid 36321894)
52. Fan L Y., Tu X Q., Zhu Y et al. Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. World J Gastroenterol 2005 11 18 2768-2772 (Pubitemid 40704245)
53. Gordon M A., Oppenheim E, Camp N J., di Giovine F S., Duff G W., Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol 1999 31 2 242-247 (Pubitemid 29349749)
54. Tanaka A, Quaranta S, Mattalia A et al. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J Hepatol 1999 30 5 826-829 (Pubitemid 29248982)
55. Niro G A., Poli F, Andriulli A et al. TNF-alpha polymorphisms in primary biliary cirrhosis: a northern and southern Italian experience. Ann N Y Acad Sci 2009 1173 557-563
56. Graham A M., Dollinger M M., Howie S E., Harrison D J. Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: analysis of allele frequencies in primary biliary cirrhosis. J Med Genet 2000 37 2 150-152 (Pubitemid 30245904)
57. Agarwal K, Czaja A J., Jones D E., Donaldson P T. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000 31 1 49-53 (Pubitemid 30033688)
58. Bittencourt P L., Palcios S A., Farias A Q. et al. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2003 18 9 1061-1066
59. Joshita S, Umemura T, Yoshizawa K et al, Shinshu PBC Study Group. Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. J Hepatol 2010 53 3 537-541
60. Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001 48 3 397-402 (Pubitemid 32269570)
61. Lakatos L P., Bajnok E, Hegedus D, Tth T, Lakatos P, Szalay F. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2002 14 7 733-740 (Pubitemid 34753956)
62. Vogel A, Strassburg C P., Manns M P. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002 35 1 126-131 (Pubitemid 34032552)
63. Halmos B, Szalay F, Cserniczky T et al. Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population. Dig Dis Sci 2000 45 6 1091-1095 (Pubitemid 30409450)
64. Tanaka A, Nezu S, Uegaki S et al. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol 2009 50 6 1202-1209
65. Joshita S, Umemura T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M, Shinshu PBC Study Group. A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients. Hum Immunol 2010 71 5 520-524
66. Mells G F., Floyd J A., Morley K I. et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 2011 43 4 329-32